Zheng Huang Selected Research

2,2'-dipicolylamine

1/2022

Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zheng Huang Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 08/2002
10	Infections 01/2021 - 07/2011
8	Pain (Aches) 01/2022 - 02/2013
8	Port-Wine Stain (Nevus Flammeus) 12/2021 - 03/2006
7	Inflammation (Inflammations) 06/2022 - 09/2013
7	Rheumatoid Arthritis 07/2021 - 02/2011
7	Necrosis 09/2020 - 10/2002
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2003
6	Nasopharyngeal Carcinoma 09/2020 - 03/2006
5	Carcinogenesis 01/2019 - 02/2003
5	Condylomata Acuminata (Genital Wart) 05/2012 - 03/2006
4	Fibrosis (Cirrhosis) 01/2022 - 06/2004
4	Myocardial Infarction 10/2021 - 01/2013
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2006
4	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2018
4	Ischemia 01/2021 - 10/2013
4	Liver Neoplasms (Liver Cancer) 02/2017 - 03/2006
4	Acne Vulgaris 09/2016 - 03/2010
4	Carcinoma (Carcinomatosis) 01/2015 - 08/2002
4	Prostatic Neoplasms (Prostate Cancer) 12/2007 - 10/2002
3	Cicatrix (Scar) 01/2022 - 12/2012
3	Lordosis 01/2022 - 02/2021
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 09/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2021 - 05/2005
3	Rupture 07/2021 - 11/2017
3	Premature Birth (Birth, Premature) 01/2021 - 01/2017
3	Birth Weight (Birth Weights) 01/2021 - 01/2017
3	Diarrhea 11/2019 - 12/2011
3	Pregnancy Complications 10/2018 - 01/2017
3	Moyamoya Disease (Moya-Moya Disease) 07/2017 - 02/2011
3	Hypoxia (Hypoxemia) 07/2017 - 08/2002
3	Glioma (Gliomas) 02/2013 - 09/2008
3	Obesity 01/2012 - 03/2010
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2006 - 08/2005
2	Vulvar Lichen Sclerosus 09/2022 - 06/2016
2	Arteriovenous Malformations (Arteriovenous Malformation) 06/2022 - 01/2022
2	Hemorrhage 05/2022 - 08/2018
2	Hypertension (High Blood Pressure) 01/2022 - 01/2018
2	Thrombosis (Thrombus) 10/2021 - 01/2018
2	Death (Near-Death Experience) 10/2021 - 01/2013
2	Body Weight (Weight, Body) 08/2021 - 03/2010
2	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 06/2019
2	Aneurysm (Aneurysms) 04/2020 - 08/2018
2	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 08/2005
2	Infarction (Infarctions) 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2018
2	Cognitive Dysfunction 01/2020 - 11/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2016
2	Arthritis (Polyarthritis) 01/2019 - 09/2013

Drug/Important Bio-Agent (IBA)

40	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 08/2002
13	AcidsIBA 09/2016 - 09/2007
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2003
10	Pharmaceutical PreparationsIBA 01/2022 - 07/2011
8	Photosensitizing Agents (Photosensitizers)IBA 11/2020 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2008
5	CateninsIBA 01/2021 - 05/2012
5	Biological ProductsIBA 01/2021 - 09/2012
5	Aminolevulinic Acid (Levulan)FDA Link 01/2017 - 12/2008
5	Stearoyl-CoA DesaturaseIBA 01/2012 - 03/2010
5	Phosphodiesterase 4 InhibitorsIBA 11/2010 - 10/2002
5	palladium-bacteriopheophorbideIBA 12/2007 - 10/2002
4	Therapeutic UsesIBA 01/2022 - 01/2006
4	LigandsIBA 10/2021 - 10/2013
4	SolutionsIBA 02/2018 - 09/2007
4	CadmiumIBA 01/2018 - 01/2017
4	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2018 - 08/2002
3	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2013
3	protoporphyrin IXIBA 01/2017 - 09/2007
3	Messenger RNA (mRNA)IBA 01/2016 - 02/2011
3	hematoporphyrin monomethyl etherIBA 02/2013 - 09/2010
2	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2022
2	LipidsIBA 01/2022 - 01/2006
2	Adenosine Triphosphate (ATP)IBA 10/2021 - 08/2002
2	devimistatIBA 10/2021 - 04/2020
2	CollagenIBA 10/2021 - 09/2013
2	Complement System Proteins (Complement)IBA 07/2021 - 01/2020
2	Circular RNAIBA 01/2021 - 03/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2021 - 06/2019
2	NF-kappa B (NF-kB)IBA 11/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2011
2	Troponin T (Troponin T1)IBA 01/2020 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 01/2020
2	MB Form Creatine KinaseIBA 01/2020 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2011
2	Oxygen (Dioxygen)IBA 06/2019 - 08/2002
2	Histone DemethylasesIBA 01/2019 - 01/2018
2	EnzymesIBA 01/2019 - 09/2014
2	VanadiumIBA 10/2018 - 01/2017

Therapy/Procedure

40	Photochemotherapy (Photodynamic Therapy) 12/2021 - 08/2002
15	Therapeutics 10/2021 - 10/2002
5	Aftercare (After-Treatment) 01/2021 - 10/2011
4	Lasers (Laser) 03/2014 - 08/2002
3	Ischemic Postconditioning 01/2020 - 01/2020
3	Dye Lasers 12/2014 - 03/2008
2	Stents 01/2022 - 10/2021
2	Operative Time 12/2021 - 01/2021
2	Mechanical Ventilators (Ventilator) 06/2021 - 01/2021
2	Immunotherapy 01/2021 - 01/2006